Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2022-01-13 00:00:00 ET · period of report 2022-01-11 · accession 0001062993-22-001041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-13 | 2022-01-11 | ENTA | Adda Nathalie | SVP, Chief Medical Off | S - Sale+OE | $70.13 | -12.5K | 32.9K | -28% | -$879.1K |
| DM | 2022-01-13 | 2022-01-11 | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $39.88 | +12.5K | 42.1K | +42% | +$499.9K |
| DM | 2022-01-13 | 2022-01-11 | ENTA | Adda Nathalie | SVP, Chief Medical Off | M - OptEx | $0.00 | -12.5K | 31.7K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-11 | S | D | 12,536 | $70.13 | 32,902 | D | — | — | (F2) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.90, inclusive. |
| 2 | Common | Common Stock | 2022-01-11 | M | A | 3,336 | $30.00 | 45,438 | D | — | — | |
| 3 | Common | Common Stock | 2022-01-11 | M | A | 9,200 | $43.46 | 42,102 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-01-11 | M | D | 9,200 | $0.00 | 36,820 | D | $43.46 · — to 2025-06-29 | 9,200 Common Stock | (F3) 100% of the shares subject to the option are fully vested and exercisable. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-01-11 | M | D | 3,336 | $0.00 | 31,664 | D | $30.00 · — to 2026-11-18 | 3,336 Common Stock | (F3) 100% of the shares subject to the option are fully vested and exercisable. |